Ironwood Pharmaceuticals (IRWD) Capital Expenditures Growth (5y) (2015 - 2025)
Ironwood Pharmaceuticals (IRWD) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Ironwood Pharmaceuticals | 646.45 Mn | 425.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.28% |
| Jun 30, 2025 | -64.91% |
| Mar 31, 2025 | -53.58% |
| Sep 30, 2024 | -65.07% |
| Jun 30, 2024 | -52.63% |
| Mar 31, 2024 | 15.65% |
| Dec 31, 2023 | -3.64% |
| Sep 30, 2023 | 15.28% |
| Mar 31, 2023 | -61.36% |
| Dec 31, 2022 | 41.85% |
| Sep 30, 2022 | -46.19% |
| Jun 30, 2022 | -34.12% |
| Mar 31, 2022 | -61.30% |
| Dec 31, 2021 | -36.06% |
| Jun 30, 2020 | -15.11% |
| Mar 31, 2020 | -6.26% |
| Dec 31, 2019 | -38.61% |
| Sep 30, 2019 | 45.25% |
| Jun 30, 2019 | 27.25% |
| Mar 31, 2019 | -22.54% |